|Application ||WB, E|
|Other Accession||Q80UN1, NP_060104.2|
|Calculated MW||42567 Da|
|Antigen Region||179-207 aa|
|Other Names||BTB/POZ domain-containing protein KCTD9, KCTD9|
|Target/Specificity||This KCTD9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 179-207 amino acids from the Central region of human KCTD9.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||KCTD9 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
KCTD9 contains a potassium channel tetramerisation domain. The N-terminal, cytoplasmic tetramerisation domain (T1) of voltage-gated potassium channels encodes molecular determinants for subfamily-specific assembly of alpha-subunits into functional tetrameric channels. The specific function of KCTD9 is unknown.
Zhou, Y.Y., et al. Zhonghua Gan Zang Bing Za Zhi 16(11):835-839(2008)
Lamesch, P., et al. Genomics 89(3):307-315(2007)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.